SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-03-022150
Filing Date
2003-09-18
Accepted
2003-09-18 18:56:18
Documents
1
Period of Report
2003-09-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION boc79643_04aak.html 4  
1 MAIN DOCUMENT DESCRIPTION boc79643_04aak.xml 4 2410
  Complete submission text file 0001209191-03-022150.txt   4339
Mailing Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045
Business Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045 847-573-8990
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 197 CEDAR ST ENGLEWOOD NJ 07631 2123692490
KORNBLUTH ARTHUR ASHER (Reporting) CIK: 0001213808 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 03901787